NASDAQ:PIII

P3 Health Partners Stock News

Healthcare > Medical - Care Facilities

Buy PIII

*Your capital is at risk

$10.05

-2.74 (-21.42%)

At Close: Jun 03, 2026

Financial Review: P3 Health Partners (NASDAQ:PIII) vs. Clover Health Investments (NASDAQ:CLOV)

01:30am, Monday, 20'th Oct 2025

P3 Health Partners (NASDAQ: PIII - Get Free Report) and Clover Health Investments (NASDAQ: CLOV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare

P3 Health Partners to Participate in the Jefferies Healthcare Services Conference

04:05pm, Wednesday, 17'th Sep 2025

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate

Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States

09:30am, Monday, 25'th Aug 2025

GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which offic

P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript

10:20pm, Thursday, 14'th Aug 2025

P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Amir Bacchus - Co-Founder, Chief Medical Officer & Director Aric Coffman - CEO,

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

06:15pm, Thursday, 14'th Aug 2025

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago.

P3 Health Partners Announces Second Quarter 2025 Results

04:05pm, Thursday, 14'th Aug 2025

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its